Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery

3Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: To analyze the number of HSCTs performed in 2019 vs. 2020 and report the status of transplant centers (TCs) during and a year after the COVID-19 pandemic. Methods: We performed a comprehensive cross-sectional nationwide study including active TCs interrogating HSCT activity from 2019 through September 2021. An electronic survey was sent to TCs and consisted of items regarding the number and characteristics of procedures performed and were compared yearly. Changes to their institutions’ transplant policies and practices during the COVID19 pandemic were also documented. Fifty centers were invited to participate, 33 responded. Results: Most TCs were part of the public health system (63.7%). Almost half are in the country’s capital, Mexico City (45.5%). Most centers performed <10 procedures per year. The number of HSCTs decreased from 835 in 2019–505 in 2020 (p

Cite

CITATION STYLE

APA

León, A. G. D., Gil-Flores, L., Colunga-Pedraza, P., Bourlon, C., Vargas-Serafín, C., del Campo-Martínez, M. de los Á., … Gómez-Almaguer, D. (2022). Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery. Hematology (United Kingdom), 27(1), 1294–1300. https://doi.org/10.1080/16078454.2022.2156737

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free